BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 22223693)

  • 1. Sleeve lobectomy after induction chemoradiotherapy.
    Gómez-Caro A; Boada M; Reguart N; Viñolas N; Casas F; Molins L
    Eur J Cardiothorac Surg; 2012 May; 41(5):1052-8. PubMed ID: 22223693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.
    Milman S; Kim AW; Warren WH; Liptay MJ; Miller C; Basu S; Faber LP
    Ann Thorac Surg; 2009 Sep; 88(3):945-50; discussion 950-1. PubMed ID: 19699925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morbidity, mortality, and long-term survival after sleeve lobectomy for non-small cell lung cancer.
    Yildizeli B; Fadel E; Mussot S; Fabre D; Chataigner O; Dartevelle PG
    Eur J Cardiothorac Surg; 2007 Jan; 31(1):95-102. PubMed ID: 17126556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of surgical results after pneumonectomy and sleeve lobectomy for non-small cell lung cancer: trends over time and 20-year institutional experience.
    Takeda S; Maeda H; Koma M; Matsubara Y; Sawabata N; Inoue M; Tokunaga T; Ohta M
    Eur J Cardiothorac Surg; 2006 Mar; 29(3):276-80. PubMed ID: 16434204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
    Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results of sleeve lobectomy in the management of non-small cell lung carcinoma and low-grade neoplasms.
    Merritt RE; Mathisen DJ; Wain JC; Gaissert HA; Donahue D; Lanuti M; Allan JS; Morse CR; Wright CD
    Ann Thorac Surg; 2009 Nov; 88(5):1574-81; discussion 1581-2. PubMed ID: 19853115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sleeve resections with unprotected bronchial anastomoses are safe even after neoadjuvant therapy.
    Storelli E; Tutic M; Kestenholz P; Schneiter D; Opitz I; Hillinger S; Weder W
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):77-81. PubMed ID: 22290903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of induction therapy on airway complications after sleeve lobectomy for lung cancer.
    Gonzalez M; Litzistorf Y; Krueger T; Popeskou SG; Matzinger O; Ris HB; Gronchi F; Lovis A; Peters S
    Ann Thorac Surg; 2013 Jul; 96(1):247-52. PubMed ID: 23684158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleeve lobectomy versus pneumonectomy for lung cancer: a comparative analysis of survival and sites or recurrences.
    Deslauriers J; Grégoire J; Jacques LF; Piraux M; Guojin L; Lacasse Y
    Ann Thorac Surg; 2004 Apr; 77(4):1152-6; discussion 1156. PubMed ID: 15063224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local control of disease related to lymph node involvement in non-small cell lung cancer after sleeve lobectomy compared with pneumonectomy.
    Kim YT; Kang CH; Sung SW; Kim JH
    Ann Thorac Surg; 2005 Apr; 79(4):1153-61; discussion 1153-61. PubMed ID: 15797043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of sleeve resections in advanced nodal disease.
    Schirren J; Eberlein M; Fischer A; Bölükbas S
    Eur J Cardiothorac Surg; 2011 Nov; 40(5):1157-63. PubMed ID: 21454086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary resection after concurrent chemotherapy and high dose (60Gy) radiation for non-small cell lung cancer is safe and may provide increased survival.
    Cerfolio RJ; Bryant AS; Jones VL; Cerfolio RM
    Eur J Cardiothorac Surg; 2009 Apr; 35(4):718-23; discussion 723. PubMed ID: 19233668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sacrificing the pulmonary arterial branch to the spared lobe is a risk factor of bronchopleural fistula in sleeve lobectomy after chemoradiotherapy.
    Toyooka S; Soh J; Shien K; Sugimoto S; Yamane M; Oto T; Date H; Miyoshi S
    Eur J Cardiothorac Surg; 2013 Mar; 43(3):568-72. PubMed ID: 22659891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quarter of a century experience with sleeve lobectomy for non-small cell lung cancer.
    Rea F; Marulli G; Schiavon M; Zuin A; Hamad AM; Rizzardi G; Perissinotto E; Sartori F
    Eur J Cardiothorac Surg; 2008 Sep; 34(3):488-92; discussion 492. PubMed ID: 18579399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study on perioperative risks and functional results in bronchial and bronchovascular sleeve resections.
    Schirren J; Bölükbas S; Bergmann T; Fisseler-Eckhoff A; Trainer S; Beqiri S
    Thorac Cardiovasc Surg; 2009 Feb; 57(1):35-41. PubMed ID: 19169995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of morbidity, 30-day mortality, and long-term survival after pneumonectomy and sleeve lobectomy for non-small cell lung carcinoma.
    Ludwig C; Stoelben E; Olschewski M; Hasse J
    Ann Thorac Surg; 2005 Mar; 79(3):968-73. PubMed ID: 15734415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation therapy oncology group protocol 02-29: a phase II trial of neoadjuvant therapy with concurrent chemotherapy and full-dose radiation therapy followed by surgical resection and consolidative therapy for locally advanced non-small cell carcinoma of the lung.
    Suntharalingam M; Paulus R; Edelman MJ; Krasna M; Burrows W; Gore E; Wilson LD; Choy H
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):456-63. PubMed ID: 22543206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer.
    Weder W; Collaud S; Eberhardt WE; Hillinger S; Welter S; Stahel R; Stamatis G
    J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1424-30. PubMed ID: 20416887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgery for patients with persistent pathological N2 IIIA stage in non-small-cell lung cancer after induction radio-chemotherapy: the microscopic seed of doubt.
    Meacci E; Cesario A; Cusumano G; Lococo F; D'Angelillo R; Dall'armi V; Margaritora S; Granone P
    Eur J Cardiothorac Surg; 2011 Sep; 40(3):656-63. PubMed ID: 21402479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.